SCHEMBL5223291

SCHEMBL5223291

CN(c1ccc2c(c1)nc(NC(=O)c1cc(C(F)(F)F)ccc1F)n2C)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1

nearest known ligand 0.65

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KDR P35968 17/20 0.65
AURKA O14965 1/20 0.48
RIPK1 Q13546 1/20 0.46
MLKL Q8NB16 1/20 0.46
RIPK3 Q9Y572 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4976995 0.88 KDR (0.69) KDRAURKARIPK1MLKLRIPK3
SCHEMBL4992307 0.87 KDR (0.60) KDRAURKA
SCHEMBL5227229 0.86 KDR (0.57) KDRAURKA
SCHEMBL4979108 0.85 KDR (0.57) KDRAURKA
SCHEMBL4980432 0.85 KDR (0.58) KDRAURKA
SCHEMBL4976825 0.84 KDR (0.61) KDRAURKARIPK1MLKLRIPK3
SCHEMBL4983882 0.84 KDR (0.56) KDR
SCHEMBL4976937 0.84 KDR (0.58) KDRAURKA
Trifluoroacetic Acid SCHEMBL5228503 0.83 KDR (0.55) KDRAURKA
SCHEMBL5226927 0.83 KDR (0.58) KDRAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7338959-B2 Diamino-pyrimidines and their use as angiogenesis inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-03-04 US disclosed
US-7338959-B2 Diamino-pyrimidines and their use as angiogenesis inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-03-04 US disclosed
EP-1487824-B1 DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORP (US) 2007-06-20 EP disclosed
EP-1487824-B1 DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORP (US) 2007-06-20 EP disclosed